Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #150, May 2020
A New Jersey federal judge has dismissed Eastman Kodak Inc. from a lawsuit alleging injuries caused by a medical imaging dye, ruling that a federal bankruptcy court order bars the plaintiffs’ claims because they were afforded due process.
The judge overseeing the federal BHR Hip MDL docket has denied Smith & Nephew’s request for an amended order further limiting the scope of ex parte conversations between surgeons and plaintiff’s counsel, finding no justification for such an order.
In addressing defendants’ motion for summary judgment in an Ethicon pelvic mesh action, a Nevada federal judge has predicted the state supreme court would apply the learned intermediary doctrine in product liability failure-to-warn cases.
A Connecticut man has sued Smith & Nephew Inc. and a bone cement manufacturer, alleging his artificial knee prematurely failed, causing him severe injuries, requiring multiple surgeries.
A New Jersey federal judge has refused to remand a gadolinium-based contrast agent (GBCA) case to state court, ruling that the complaint raises claims “that necessarily depend on resolution of a substantial question of federal law.”
A Georgia lawyer has hit the makers of Zantac with a federal lawsuit, alleging that “staggering amounts” of N-nitrosodimethylamine (NDMA) in the popular over-the-counter antacid caused his stage 3 colon cancer.
The Food and Drug Administration has cautioned consumers and health professionals against using hydroxychloroquine and chloroquine to treat non-hospitalized patients for COVID-19 or to prevent the virus, explaining that it can lead to life-threatening heart rhythm problems.
An Illinois federal judge has awarded Johnson & Johnson and Ethicon Inc. summary judgment on the remaining claims in a pelvic mesh action, finding they are time-barred under the state’s two-year statute of limitations.
An Alabama federal judge has awarded Ethicon Inc. and Johnson & Johnson summary judgment in a pelvic mesh action, ruling that the plaintiffs’ claims are time-barred under the state’s two-year statute of limitations.
Rachel A. Remke of Schiff Hardin discusses a proposed amendment to Federal Rule of Civil Procedure 30(b)(6) that requires parties to confer in good faith before the deposition takes place about both the topics and the identity of the witness or witnesses.